The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen
Research Funding - Amgen
Cardiac safety of the trastuzumab biosimilar ABP 980 in women with HER2-positive early breast cancer in the LILAC study.
 
Hans-Christian Kolberg
Stock and Other Ownership Interests - Phaon Scientific; Theraclion
Honoraria - Amgen; AstraZeneca; Carl Zeiss Meditec; Genomic Health; Novartis; Pfizer; Roche; SurgVision; Theraclion
Consulting or Advisory Role - SurgVision
Travel, Accommodations, Expenses - Amgen; Carl Zeiss Meditec; Daiichi Sankyo; Genomic Health; LIV Pharma; Novartis; Pfizer; Roche; Tesaro
 
Marco Colleoni
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Celldex; OBI Pharma; Pfizer; Pierre Fabre; Puma Biotechnology
 
Georgia Demetriou
Honoraria - Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Profmed
Speakers' Bureau - Merck Serono
Travel, Accommodations, Expenses - Key Oncologics; Merck Serono
 
Patricia Xavier Santi
No Relationships to Disclose
 
Hans Tesch
No Relationships to Disclose
 
Yasuhiro Fujiwara
Honoraria - AstraZeneca Japan; Daiichi Sankyo; SRL Diagnostics
Consulting or Advisory Role - AstraZeneca Japan; Bristol-Myers Squibb Japan
 
Zorica Tomasevic
Honoraria - Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Roche
 
Vladimir Hanes
Employment - Amgen
Stock and Other Ownership Interests - Amgen